Your browser doesn't support javascript.
loading
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections.
Brazer, Noah; Morris, Mary Kate; Servellita, Venice; Anglin, Khamal; Saldhi, Prachi; Garcia-Knight, Miguel; Bethancourt, Sutana; Sotomayor-Gonzalez, Alicia; Wang, Baolin; Foresythe, Abiodun; Nguyen, Jenny; Gliwa, Amelia S; Pineda-Ramirez, Jesus; Sanchez, Ruth Diaz; Zhang, Yueyuan; Ott, Melanie; Wadford, Debra A; Andino, Raul; Kelly, J Daniel; Hanson, Carl; Chiu, Charles Y.
Affiliation
  • Brazer N; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Morris MK; California Department of Public Health, Viral and Rickettsial Disease Laboratory, Richmond, California, USA.
  • Servellita V; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Anglin K; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
  • Saldhi P; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Garcia-Knight M; Department of Microbiology and Immunology, University of California, San Francisco, California, USA.
  • Bethancourt S; California Department of Public Health, Viral and Rickettsial Disease Laboratory, Richmond, California, USA.
  • Sotomayor-Gonzalez A; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Wang B; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Foresythe A; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Nguyen J; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Gliwa AS; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Pineda-Ramirez J; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
  • Sanchez RD; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
  • Zhang Y; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Ott M; California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, California, USA.
  • Wadford DA; Gladstone Institutes, San Francisco, California, USA.
  • Andino R; Innovative Genomics Institute, University of California, Berkeley, California, USA.
  • Kelly JD; Department of Medicine, University of California, San Francisco, California, USA.
  • Hanson C; California Department of Public Health, Viral and Rickettsial Disease Laboratory, Richmond, California, USA.
  • Chiu CY; Department of Microbiology and Immunology, University of California, San Francisco, California, USA.
J Infect Dis ; 226(10): 1688-1698, 2022 11 11.
Article in En | MEDLINE | ID: mdl-36134603
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Antibodies, Neutralizing Limits: Humans Language: En Journal: J Infect Dis Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Antibodies, Neutralizing Limits: Humans Language: En Journal: J Infect Dis Year: 2022 Type: Article Affiliation country: United States